Paper Details

  1. Home
  2. Paper Details

Flunisolide--a new intranasal steroid for the treatment of allergic rhinitis.

Author: ChatterjeeS S, EnglerC, SahayJ N

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A study of 50 patients with perennial allergic rhinitis found that flunisolide nasal spray (200 micrograms daily) was significantly more effective than a placebo in reducing symptoms of sneezing, nasal congestion, post-nasal drip, and improving sleep and daily life. Both patients and doctors preferred the flunisolide spray. Minor side effects were reported during both placebo and flunisolide phases, and no evidence of adrenal suppression was observed.
Paper Details　
Original Abstract of the Article :
A double-blind, cross-over comparison of flunisolide nasal spray and its inactive aqueous vehicle has been carried out in fifty patients suffering from perennial allergic rhinitis. Patients were randomly allocated to two groups; the first group (group I) received flunisolide for 3 weeks and then pla...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1365-2222.1979.tb01518.x

データ提供：米国国立医学図書館（NLM）

Flunisolide: A New Nasal Spray for Allergic Rhinitis

Allergic rhinitis, commonly known as hay fever, can make life miserable with its itchy eyes, runny nose, and sneezing fits. This double-blind, cross-over study evaluated the effectiveness of flunisolide nasal spray, a new intranasal steroid, in treating perennial allergic rhinitis. Fifty patients were randomly assigned to receive either flunisolide or a placebo for three weeks, then switched to the other treatment for another three weeks. The results showed that flunisolide was significantly superior to placebo in relieving symptoms like sneezing, nasal obstruction, and postnasal drip. The study also found that flunisolide improved sleep quality and overall quality of life. This research suggests that flunisolide may be an effective and well-tolerated treatment option for allergic rhinitis.

Flunisolide's Potential: An Oasis in the Desert of Allergies

The study demonstrates the effectiveness of flunisolide as a treatment for allergic rhinitis, offering a potential oasis in the desert of allergy symptoms. It's a promising development, as it offers a new treatment option that could alleviate the suffering of many individuals. Imagine a world where allergy symptoms are a thing of the past - a desert transformed into a blooming garden!

Managing Allergies: A Camel's Wisdom

If you're struggling with allergic rhinitis, consult with your doctor to discuss available treatment options. They can help you navigate the desert of allergies and find the solution that best fits your needs. Remember, early intervention and proper management are key to controlling your allergies and enjoying life to the fullest. Just as a camel finds its way through the desert using its senses and instincts, you can learn to navigate your allergies with knowledge and awareness.

Dr. Camel's Conclusion

Flunisolide nasal spray shows promise as an effective treatment for allergic rhinitis, offering a potential oasis in the desert of allergy symptoms. This research highlights the importance of exploring new treatment options for allergy sufferers, seeking solutions that can alleviate their discomfort and improve their quality of life.

Date :
  1. Date Completed 1979-05-23
  2. Date Revised 2021-09-01
Further Info :

Pubmed ID

369735

DOI: Digital Object Identifier

10.1111/j.1365-2222.1979.tb01518.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.